Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures
Status:
Withdrawn
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
Introduction:
Opioids, such as morphine, act at receptors in the central nervous system, but many studies
have suggested direct action peripherally on opioid receptors in sensory neurons terminals,
melanocytes, keratinocytes and fibroblasts. These receptors are stimulated when occurs
inflammatory processes.
Hypothesis:
Treatment with topical morphine 0.1% applied 30 minutes before an invasive procedure,
decreases pain in children.
Method:
A randomised double-blind parallel study to evaluate the effect of topical application of a
0.1% morphine gel in patients undergo a procedure. 22 patients in each group will be
included. Randomly assigned to either the morphine gel or a placebo hydrogel, it will be
applied 30 minutes before the procedure and the first day every 4 hours. General basic
sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be
measured with "Face, Legs, Activity, Cry, Consolability scale" (FLACC scale).